About Hindustan Bio Sciences Limited
Data last updated: 14 July 2026
Hindustan Bio Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 16 December 1991, the company has been in operation for over 35 years.
Registered with ROC Hyderabad under CIN L26942TG1991PLC013564. Listed on BSE: 532041.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹2.05 Cr. It is led by directors including Uma Jampana and Venkata Rama Mohan Raju Jampana.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.31Sagar Society Road No.2 Banjarahills, Hyderabad, Telangana, India – 500034.
As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹73.71 Lakh, a decline of 9.37% compared to the previous year. The net worth stands at ₹82.6 Lakh (down 8.73% YoY). Total assets are valued at ₹3.2 Cr (down 6.67% YoY).
The company is associated with 1 brand - Hindustan Bio Sciences Limited. As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹14.7 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hindustanbiosciences.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPlot No.31Sagar Society Road No.2 Banjarahills, Hyderabad, Telangana, India – 500034
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L26942TG1991PLC013564, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L26942TG1991PLC013564 | Current |
| U26942AP1991PLC013564 | Previous |
| L26942AP1991PLC013564 | Previous |
Associated Brands with Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited operates one associated brand: Hindustan Bio Sciences Limited. These brands represent Hindustan Bio Sciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Hindustan Bio Sciences Limited is engaged in pharmaceutical and biotechnology operations. | hindustanbiosciences.in |
Competitors & Alternatives of Hindustan Bio Sciences Limited
Brands and companies operating in the same space as Hindustan Bio Sciences Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Jubilant Life Sciences
|
Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India, India | 1978 |
Akums
|
CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India, India | 2004 |
Nectar Lifesciences
|
Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India, India | 1995 |
Windlas
|
Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India, India | 2001 |
Unither
|
Contract development and manufacturing organization for proprietary and generic drugs | Paris, France, France | 1993 |
Recipharm
|
Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden, Sweden | 1995 |
CoreRx
|
CDMO with a focus on early phase drug product development | Clearwater, United States, United States | 2006 |
MedPharm
|
Topical and inhaled drug delivery formulations are developed and manufactured. | Guildford, United Kingdom, United Kingdom | 1998 |
Business Activity of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Hindustan Bio Sciences Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is audited by VASG & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-04-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| VASG & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-04-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is currently managed by 6 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uma Jampana | Director | 30 Oct 2007 | 18 Years 9 Months | Current |
|
Venkata Rama Mohan Raju Jampana
Also directs:
Hindustan Bio Sciences Limited, Basix Infratech India Private Limited, Nipuna Shelters Private Limited and 1 more
|
Managing Director | 10 Jun 2000 | 26 Years 2 Months | Current |
|
Nagi Reddy Bodeddula
Also directs:
Hindustan Bio Sciences Limited, Sendcrux Labs Private Limited
|
Director | 30 Sep 2024 | 1 Years 10 Months | Current |
|
Pratheek Reddy Gorrela
Also directs:
Hindustan Bio Sciences Limited, Trans East Infra Llp, Misty Fall Valley Private Limited and 1 more
|
Director | 30 Sep 2024 | 1 Years 10 Months | Current |
|
Jaison George
Also directs:
Hindustan Bio Sciences Limited, Aiwon Life Sciences Llp, Harvey Life Sciences Private Limited and 1 more
|
Director | 31 Oct 2023 | 2 Years 9 Months | Current |
| Reji Abraham | Director | 31 Oct 2023 | 2 Years 9 Months | Current |
Financials of Hindustan Bio Sciences Limited FY 2026 filings available
Hindustan Bio Sciences Limited reported revenue of ₹73.71 Lakh (down 9.37% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹73.71 Lakh | ₹81.33 Lakh | ₹1.03 Cr | ₹92.23 Lakh | ₹43.65 Lakh | ₹1.03 Cr | ₹1.94 Cr | ₹3.56 Cr |
| Other Income | ₹0 | ₹0 | ₹2.4 Lakh | ₹0 | ₹5.24 Lakh | ₹0 | ₹0 | ₹6,000 |
| Total Income | ₹73.71 Lakh | ₹81.33 Lakh | ₹1.05 Cr | ₹92.23 Lakh | ₹48.89 Lakh | ₹1.03 Cr | ₹1.94 Cr | ₹3.56 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹44.9 Lakh | ₹49.39 Lakh | ₹64.25 Lakh | ₹57.03 Lakh | ₹28.93 Lakh | ₹34.03 Lakh | ₹1.53 Cr | ₹2.92 Cr |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹34.01 Lakh | -₹22.63 Lakh | -₹3.45 Lakh |
| Employee Benefit Expense | ₹19.35 Lakh | ₹12.58 Lakh | ₹14.56 Lakh | ₹23.92 Lakh | ₹24.05 Lakh | ₹24.64 Lakh | ₹25.73 Lakh | ₹22.41 Lakh |
| Finance Costs | ₹11,000 | ₹14,000 | ₹37,000 | ₹41,000 | ₹50,000 | ₹69,000 | ₹82,000 | ₹1.04 Lakh |
| Depreciation & Amortisation | ₹1.99 Lakh | ₹2,000 | ₹68,000 | ₹56,500 | ₹34,000 | ₹80,000 | ₹1.14 Lakh | ₹1.07 Lakh |
| Other Expenses | ₹15.29 Lakh | ₹9.38 Lakh | ₹20.08 Lakh | ₹14.1 Lakh | ₹46.52 Lakh | ₹1.05 Cr | ₹24.93 Lakh | ₹31.97 Lakh |
| Total Expenses | ₹81.64 Lakh | ₹71.51 Lakh | ₹99.94 Lakh | ₹96.03 Lakh | ₹1 Cr | ₹1.99 Cr | ₹1.83 Cr | ₹3.45 Cr |
| Profit Before Exceptional Items & Tax | -₹7.93 Lakh | ₹9.82 Lakh | ₹5.34 Lakh | -₹3.8 Lakh | -₹51.45 Lakh | -₹95.53 Lakh | ₹11.65 Lakh | ₹11.23 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹7.93 Lakh | ₹9.82 Lakh | ₹5.34 Lakh | -₹3.8 Lakh | -₹51.45 Lakh | -₹95.53 Lakh | ₹11.65 Lakh | ₹11.23 Lakh |
| Total Tax Expense | -₹3,000 | -₹26,000 | -₹43,000 | ₹25,000 | ₹31,000 | -₹1.55 Lakh | ₹3.56 Lakh | ₹23,000 |
| Net Profit | -₹7.9 Lakh | ₹10.08 Lakh | ₹5.77 Lakh | -₹4.05 Lakh | -₹51.76 Lakh | -₹93.98 Lakh | ₹8.09 Lakh | ₹11 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹7.9 Lakh | ₹10.08 Lakh | ₹5.77 Lakh | -₹4.05 Lakh | -₹51.76 Lakh | -₹93.98 Lakh | ₹8.09 Lakh | ₹11 Lakh |
| EBITDA (computed) | -₹5.83 Lakh | ₹9.98 Lakh | ₹6.39 Lakh | -₹2.82 Lakh | -₹50.61 Lakh | -₹94.04 Lakh | ₹13.61 Lakh | ₹13.34 Lakh |
| Basic EPS | ₹-0.08 | ₹0.10 | ₹0.06 | ₹-0.04 | ₹-0.50 | ₹-0.92 | ₹0.08 | ₹0.11 |
| Diluted EPS | ₹-0.08 | ₹0.10 | ₹0.00 | ₹0.00 | ₹-0.50 | ₹-0.92 | ₹0.08 | ₹0.11 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3.2 Cr | ₹3.42 Cr | ₹3.37 Cr | ₹3.29 Cr | ₹2.98 Cr | ₹3.49 Cr | ₹5.56 Cr | ₹5.63 Cr |
| Non-current Assets | ₹2.42 Cr | ₹2.43 Cr | ₹2.42 Cr | ₹2.43 Cr | ₹2.44 Cr | ₹2.59 Cr | ₹3.6 Cr | ₹3.63 Cr |
| Current Assets | ₹77.21 Lakh | ₹99.7 Lakh | ₹95 Lakh | ₹85.97 Lakh | ₹54.07 Lakh | ₹89.73 Lakh | ₹1.96 Cr | ₹2 Cr |
| Property, Plant & Equipment | ₹1.34 Lakh | ₹2.71 Lakh | ₹2.73 Lakh | ₹3.41 Lakh | ₹3.98 Lakh | ₹3.97 Lakh | ₹4.77 Lakh | ₹5.91 Lakh |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹34.01 Lakh | ₹11.38 Lakh |
| Trade Receivables | ₹5.31 Lakh | ₹44.2 Lakh | ₹44.21 Lakh | ₹45.36 Lakh | ₹13.5 Lakh | ₹81.3 Lakh | ₹1.36 Cr | ₹1.67 Cr |
| Cash & Equivalents | ₹13.03 Lakh | ₹13,000 | ₹11,000 | ₹36,000 | ₹41,000 | ₹1.2 Lakh | ₹84,000 | ₹57,000 |
| Equity (Net Worth) | ₹82.6 Lakh | ₹90.5 Lakh | ₹80.42 Lakh | ₹74.66 Lakh | ₹78.71 Lakh | ₹1.3 Cr | ₹2.24 Cr | ₹2.16 Cr |
| Equity Share Capital | ₹2.05 Cr | ₹2.05 Cr | ₹2.05 Cr | ₹2.05 Cr | ₹10.25 Cr | ₹10.25 Cr | ₹10.25 Cr | ₹10.25 Cr |
| Borrowings (Non-current) | ₹2.35 Cr | ₹2.51 Cr | ₹2.56 Cr | ₹1.12 Cr | ₹1.07 Cr | ₹73.3 Lakh | ₹1.67 Cr | ₹2.26 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹1.33 Cr | ₹1.09 Cr | ₹1.13 Cr | ₹93.1 Lakh | ₹1.1 Cr |
| Total Debt (computed) | ₹2.35 Cr | ₹2.51 Cr | ₹2.56 Cr | ₹2.46 Cr | ₹2.17 Cr | ₹1.86 Cr | ₹2.6 Cr | ₹3.37 Cr |
| Current Liabilities | ₹1.99 Lakh | ₹1.36 Lakh | ₹1.38 Lakh | ₹1.42 Cr | ₹1.12 Cr | ₹1.45 Cr | ₹1.65 Cr | ₹1.2 Cr |
| Total Liabilities | ₹2.37 Cr | ₹2.52 Cr | ₹2.57 Cr | ₹2.54 Cr | ₹2.19 Cr | ₹2.18 Cr | ₹3.31 Cr | ₹3.47 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹28.13 Lakh | ₹2.71 Lakh | -₹7.54 Lakh | -₹28.85 Lakh | -₹31.21 Lakh |
| Investing Cash Flow | -₹63,000 | ₹0 | ₹0 | ₹0 | -₹35,000 |
| Financing Cash Flow | -₹15.56 Lakh | -₹5.12 Lakh | ₹10.1 Lakh | ₹28.89 Lakh | ₹30.8 Lakh |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹35,000 |
| Free Cash Flow (computed) | ₹28.13 Lakh | ₹2.71 Lakh | -₹7.54 Lakh | -₹28.85 Lakh | -₹31.56 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹11.94 Lakh | -₹2.41 Lakh | ₹2.56 Lakh | ₹3,700 | -₹76,000 |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹38.25 Lakh | ₹0 | ₹32.19 Lakh | ₹37.53 Lakh | ₹0 | ₹0 | ₹41.11 Lakh |
| Other Income | ₹2,000 | ₹1.78 Lakh | ₹86,000 | ₹1.31 Lakh | ₹1.26 Lakh | ₹0 | ₹0 | ₹1.43 Lakh |
| Total Income | ₹2,000 | ₹40.03 Lakh | ₹86,000 | ₹33.5 Lakh | ₹38.79 Lakh | ₹0 | ₹0 | ₹42.54 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹23.71 Lakh | ₹0 | ₹21.19 Lakh | ₹23.68 Lakh | ₹0 | ₹0 | ₹25.71 Lakh |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹4.96 Lakh | ₹4.97 Lakh | ₹4.96 Lakh | ₹4.4 Lakh | ₹3.31 Lakh | ₹3.26 Lakh | ₹3.01 Lakh | ₹3.01 Lakh |
| Finance Costs | ₹0 | ₹5,000 | ₹1,000 | ₹5,000 | ₹5,000 | ₹1,000 | ₹5,000 | ₹3,000 |
| Depreciation & Amortisation | ₹42,000 | ₹1.19 Lakh | ₹39,000 | ₹0 | -₹7,000 | ₹3,000 | ₹3,000 | ₹3,000 |
| Other Expenses | ₹6.3 Lakh | ₹1.92 Lakh | ₹1.35 Lakh | ₹6.47 Lakh | ₹1.02 Lakh | ₹84,000 | ₹1.93 Lakh | ₹5.58 Lakh |
| Total Expenses | ₹11.68 Lakh | ₹31.84 Lakh | ₹6.71 Lakh | ₹32.11 Lakh | ₹27.99 Lakh | ₹4.14 Lakh | ₹5.02 Lakh | ₹34.36 Lakh |
| Profit Before Exceptional Items & Tax | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹11.66 Lakh | ₹8.19 Lakh | -₹5.85 Lakh | ₹1.39 Lakh | ₹10.8 Lakh | -₹4.14 Lakh | -₹5.02 Lakh | ₹8.18 Lakh |
| EBITDA (computed) | -₹11.24 Lakh | ₹9.43 Lakh | -₹5.45 Lakh | ₹1.44 Lakh | ₹10.78 Lakh | -₹4.1 Lakh | -₹4.94 Lakh | ₹8.24 Lakh |
| Basic EPS | ₹-0.11 | ₹0.08 | ₹-0.06 | ₹0.01 | ₹0.11 | ₹-0.40 | ₹-0.05 | ₹0.08 |
| Diluted EPS | ₹-0.11 | ₹0.08 | ₹-0.06 | ₹0.01 | ₹0.11 | ₹-0.04 | ₹-0.05 | ₹0.08 |
Shareholding Pattern of Hindustan Bio Sciences Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 12.19%, retail and other public shareholders hold 87.81% of Hindustan Bio Sciences Limited. The company had 11,530 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% | 12.19% |
| Public | 87.81% | 87.81% | 87.81% | 87.81% | 87.81% | 87.81% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 12.19% | 12.19% | 12.19% |
| Public | 87.81% | 87.81% | 87.81% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Hindustan Bio Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 1994 | Andhra Pradesh State Financial Corporation | ₹14.7 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Hindustan Bio Sciences Limited
View historical data on people associated with Hindustan Bio Sciences Limited, including employment history and EPFO contributions.
Employee and EPFO history for Hindustan Bio Sciences Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Hindustan Bio Sciences Limited
GST registrations and filing compliance for Hindustan Bio Sciences Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Hindustan Bio Sciences Limited
Credit ratings, litigation, and regulatory alerts for Hindustan Bio Sciences Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hindustan Bio Sciences Limited
MSME payment history for Hindustan Bio Sciences Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hindustan Bio Sciences Limited
Corporate group structure for Hindustan Bio Sciences Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hindustan Bio Sciences Limited
MCA filings and documents for Hindustan Bio Sciences Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Hindustan Bio Sciences Limited
Frequently Asked Questions about Hindustan Bio Sciences Limited
Hindustan Bio Sciences Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 16 December 1991 (35+ years old) and is registered under CIN L26942TG1991PLC013564. Listed on BSE: 532041.
Hindustan Bio Sciences Limited reported revenue of ₹73.71 Lakh for FY 2026 (down 9.37% YoY) based on standalone BSE filings.
The current directors of Hindustan Bio Sciences Limited are:
- Uma Jampana - Director
- Venkata Rama Mohan Raju Jampana - Managing Director
- Nagi Reddy Bodeddula - Director
- Pratheek Reddy Gorrela - Director
- Jaison George - Director
- Reji Abraham - Director
The primary industry of Hindustan Bio Sciences Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Hindustan Bio Sciences Limited is listed on BSE with code 532041.
Hindustan Bio Sciences Limited can be reached at the registered office: Plot No.31Sagar Society Road No.2 Banjarahills, Hyderabad, Telangana, India – 500034, or through the website hindustanbiosciences.in.